ECULIZUMAB

ECULIZUMAB was reported 54400 times

ECULIZUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TOTAL COMPLEMENT ACTIVITY DECREASED 49 0.8033
1 TOTAL COMPLEMENT ACTIVITY INCREASED 39 0.7358
2 HAEMOGLOBINURIA 721 0.6432
3 MALIGNANT ATROPHIC PAPULOSIS 21 0.5250
4 HAPTOGLOBIN ABNORMAL 48 0.5217
5 EXTRAVASCULAR HAEMOLYSIS 218 0.5129
6 MENINGOCOCCAL BACTERAEMIA 46 0.4792
7 COMPLEMENT FACTOR ABNORMAL 51 0.4766
8 MENINGOCOCCAL SEPSIS 86 0.4526
9 BREAKTHROUGH HAEMOLYSIS 144 0.3609
10 PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA 167 0.3561
11 MENINGITIS MENINGOCOCCAL 58 0.3412
12 COMPLEMENT FACTOR INCREASED 28 0.3333
13 HAPTOGLOBIN DECREASED 237 0.2940
14 RETICULOCYTE COUNT INCREASED 231 0.2855
15 RETICULOCYTE COUNT ABNORMAL 31 0.2768
16 MENINGOCOCCAL INFECTION 87 0.2753
17 BIOPSY BONE MARROW 126 0.2692
18 BLOOD LACTATE DEHYDROGENASE ABNORMAL 176 0.2596
19 PLASMAPHERESIS 133 0.2548
20 HAEMOLYSIS 1876 0.2427
21 C3 GLOMERULOPATHY 50 0.2415
22 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 188 0.2312
23 BLOOD PRODUCT TRANSFUSION DEPENDENT 97 0.2304
24 HAPTOGLOBIN INCREASED 29 0.2117
25 BLOOD PRODUCT TRANSFUSION 20 0.2083
26 BUDD-CHIARI SYNDROME 48 0.1897
27 BLOOD LACTATE DEHYDROGENASE DECREASED 63 0.1892
28 ARTERIOVENOUS FISTULA OCCLUSION 32 0.1829
29 NEISSERIA INFECTION 21 0.1654
30 IRON OVERLOAD 174 0.1611
31 INTRAVASCULAR HAEMOLYSIS 81 0.1446
32 MYASTHENIA GRAVIS CRISIS 209 0.1409
33 COMPLEMENT FACTOR C3 DECREASED 34 0.1393
34 IRON BINDING CAPACITY TOTAL DECREASED 30 0.1357
35 COMPLEMENT FACTOR DECREASED 24 0.1341
36 PACKED RED BLOOD CELL TRANSFUSION 166 0.1254
37 RED BLOOD CELL SCHISTOCYTES PRESENT 39 0.1204
38 HEPATIC VEIN THROMBOSIS 33 0.1044
39 PNEUMONIA ADENOVIRAL 20 0.1010
40 BLOOD LACTATE DEHYDROGENASE INCREASED 1589 0.1002
41 RETICULOCYTOSIS 21 0.0991
42 COOMBS TEST POSITIVE 27 0.0989
43 APLASTIC ANAEMIA 515 0.0985
44 NEUROMYELITIS OPTICA SPECTRUM DISORDER 128 0.0949
45 HAEMATOCRIT ABNORMAL 116 0.0943
46 HAEMOLYTIC URAEMIC SYNDROME 202 0.0871
47 THROMBOTIC MICROANGIOPATHY 831 0.0852
48 BIOPSY KIDNEY 24 0.0842
49 GONORRHOEA 22 0.0815
50 RENAL TRANSPLANT FAILURE 80 0.0810
51 HAEMOGLOBIN ABNORMAL 510 0.0792
52 PLATELET TRANSFUSION 102 0.0792
53 BONE MARROW TRANSPLANT 135 0.0711
54 MYASTHENIA GRAVIS 574 0.0710
55 ARTERIOVENOUS FISTULA OPERATION 19 0.0704
56 BLOOD IRON INCREASED 130 0.0692
57 BLOOD CREATININE ABNORMAL 235 0.0679
58 TRANSFUSION 709 0.0676
59 EXPOSURE VIA BODY FLUID 48 0.0611
60 BLOOD UREA ABNORMAL 56 0.0596
61 ARTERIOVENOUS FISTULA THROMBOSIS 20 0.0578
62 POOR VENOUS ACCESS 582 0.0562
63 RETICULOCYTE COUNT DECREASED 24 0.0557
64 GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE 29 0.0553
65 GRAFT LOSS 40 0.0552
66 SUSPECTED COVID-19 181 0.0548
67 BLUE TOE SYNDROME 21 0.0536
68 TRANSPLANTATION COMPLICATION 21 0.0500
69 RENAL TRANSPLANT 174 0.0481
70 MEAN CELL VOLUME INCREASED 121 0.0471
71 ARTERIOVENOUS FISTULA SITE COMPLICATION 28 0.0467
72 PLATELET COUNT ABNORMAL 281 0.0464
73 MEAN CELL HAEMOGLOBIN INCREASED 75 0.0453
74 TRANSFUSION REACTION 39 0.0445
75 CENTRAL VENOUS CATHETERISATION 133 0.0441
76 RED BLOOD CELL COUNT ABNORMAL 63 0.0429
77 MALIGNANT HYPERTENSION 36 0.0419
78 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 33 0.0419
79 IRREGULAR BREATHING 24 0.0409
80 MEAN PLATELET VOLUME DECREASED 34 0.0405
81 CHROMATURIA 902 0.0399
82 MULTIMORBIDITY 47 0.0393
83 HAEMOGLOBIN DECREASED 3934 0.0383
84 URINE COLOUR ABNORMAL 20 0.0351
85 EPSTEIN-BARR VIRAEMIA 38 0.0343
86 ANTIBODY TEST ABNORMAL 24 0.0333
87 POLYOMAVIRUS VIRAEMIA 35 0.0330
88 QUALITY OF LIFE DECREASED 437 0.0325
89 SERUM FERRITIN INCREASED 170 0.0322
90 BLOOD BILIRUBIN ABNORMAL 41 0.0320
91 GENE MUTATION 62 0.0313
92 CRITICAL ILLNESS 24 0.0308
93 HAEMOCHROMATOSIS 27 0.0292
94 HAEMATOCRIT DECREASED 580 0.0292
95 MASTICATION DISORDER 87 0.0284
96 MICROANGIOPATHY 26 0.0277
97 RED CELL DISTRIBUTION WIDTH INCREASED 113 0.0272
98 OESOPHAGEAL SPASM 50 0.0271
99 KIDNEY FIBROSIS 47 0.0271
100 CATHETER PLACEMENT 50 0.0269
101 CANDIDA SEPSIS 24 0.0268
102 BLOOD ALKALINE PHOSPHATASE DECREASED 25 0.0263
103 EYELID PTOSIS 250 0.0246
104 PERITONEAL DIALYSIS 20 0.0242
105 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 40 0.0240
106 BONE MARROW DISORDER 72 0.0238
107 SYMPTOM RECURRENCE 142 0.0237
108 TRANSPLANT FAILURE 57 0.0232
109 RED BLOOD CELL ABNORMALITY 22 0.0229
110 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 53 0.0226
111 ESCHERICHIA TEST POSITIVE 27 0.0225
112 KIDNEY TRANSPLANT REJECTION 107 0.0223
113 TRANSPLANT 52 0.0219
114 OCULAR ICTERUS 94 0.0217
115 TRANSPLANT REJECTION 169 0.0211
116 DEVICE RELATED INFECTION 323 0.0210
117 CARBON DIOXIDE DECREASED 24 0.0208
118 UPPER RESPIRATORY TRACT INFLAMMATION 25 0.0208
119 ANTIPHOSPHOLIPID SYNDROME 33 0.0205
120 MYELODYSPLASTIC SYNDROME 296 0.0204
121 MENINGITIS 135 0.0202
122 CATHETER SITE PAIN 52 0.0200
123 SPLENECTOMY 23 0.0198
124 GLOMERULAR FILTRATION RATE ABNORMAL 28 0.0198
125 NEPHRECTOMY 29 0.0195
126 COMPLICATIONS OF TRANSPLANTED KIDNEY 44 0.0194
127 BK VIRUS INFECTION 65 0.0193
128 GRAFT VERSUS HOST DISEASE 138 0.0192
129 MACROCYTOSIS 22 0.0190
130 VIRAL UPPER RESPIRATORY TRACT INFECTION 89 0.0187
131 GALLBLADDER ENLARGEMENT 20 0.0186
132 VACCINATION FAILURE 30 0.0180
133 WHITE BLOOD CELL DISORDER 48 0.0179
134 ADENOVIRUS INFECTION 52 0.0179
135 BLOOD CREATININE DECREASED 56 0.0179
136 PLATELET DISORDER 44 0.0174
137 DIALYSIS 247 0.0174
138 PLATELET COUNT DECREASED 1838 0.0172
139 MONOCYTE COUNT DECREASED 21 0.0172
140 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1213 0.0170
141 LABORATORY TEST ABNORMAL 480 0.0162
142 BLOOD CREATININE INCREASED 1054 0.0161
143 BLOOD PHOSPHORUS INCREASED 44 0.0161
144 PSEUDOMONAL SEPSIS 28 0.0160
145 JAUNDICE 430 0.0160
146 PRE-ECLAMPSIA 74 0.0156
147 HAEMODIALYSIS 130 0.0155
148 NORMOCYTIC ANAEMIA 22 0.0150
149 CATHETER SITE INFECTION 56 0.0148
150 BACTERAEMIA 175 0.0147
151 MENINGITIS VIRAL 20 0.0146
152 PORTAL VEIN THROMBOSIS 47 0.0145
153 BLOOD COUNT ABNORMAL 218 0.0144
154 URINARY TRACT INFECTION BACTERIAL 36 0.0142
155 RED BLOOD CELL COUNT DECREASED 407 0.0142
156 VEIN DISORDER 71 0.0142
157 NEUTROPHIL COUNT ABNORMAL 40 0.0141
158 HAEMOLYTIC ANAEMIA 123 0.0137
159 ESCHERICHIA URINARY TRACT INFECTION 58 0.0136
160 THROMBOTIC THROMBOCYTOPENIC PURPURA 48 0.0136
161 PNEUMONIA KLEBSIELLA 25 0.0136
162 BLOOD URINE PRESENT 258 0.0136
163 LUPUS NEPHRITIS 25 0.0134
164 BLOOD CHLORIDE INCREASED 23 0.0133
165 CYTOMEGALOVIRUS VIRAEMIA 57 0.0128
166 BLOOD UREA INCREASED 214 0.0128
167 ESCHERICHIA SEPSIS 37 0.0128
168 VIRAL INFECTION 422 0.0127
169 BACTERIAL SEPSIS 41 0.0126
170 PROTEINURIA 236 0.0124
171 BILIRUBIN CONJUGATED INCREASED 29 0.0124
172 ACUTE LEUKAEMIA 20 0.0124
173 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 116 0.0121
174 BLOOD BILIRUBIN INCREASED 320 0.0118
175 DYSPNOEA EXERTIONAL 445 0.0118
176 CYTOMEGALOVIRUS TEST POSITIVE 21 0.0118
177 ENDOTRACHEAL INTUBATION 33 0.0118
178 VARICELLA 28 0.0117
179 DIPLOPIA 299 0.0115
180 ESCHERICHIA BACTERAEMIA 27 0.0115
181 DEVICE RELATED SEPSIS 23 0.0114
182 ANURIA 98 0.0114
183 MONOCYTE COUNT INCREASED 41 0.0113
184 EXPOSURE DURING PREGNANCY 698 0.0112
185 CYTOMEGALOVIRUS INFECTION 186 0.0112
186 STAPHYLOCOCCAL SEPSIS 55 0.0111
187 WHITE BLOOD CELL COUNT ABNORMAL 71 0.0111
188 ENDOCARDITIS 57 0.0111
189 INFUSION SITE BRUISING 24 0.0111
190 MECHANICAL VENTILATION 21 0.0110
191 INFUSION SITE EXTRAVASATION 68 0.0109
192 BLOOD IRON DECREASED 128 0.0108
193 APLASIA 21 0.0107
194 FLUID OVERLOAD 155 0.0106
195 GLOMERULONEPHRITIS 26 0.0106
196 PSEUDOMONAS INFECTION 90 0.0105
197 BLOOD IMMUNOGLOBULIN G DECREASED 26 0.0105
198 FOOD POISONING 56 0.0104
199 GLOMERULAR FILTRATION RATE DECREASED 128 0.0104
200 FIBRIN D DIMER INCREASED 37 0.0104
201 FOETAL DISTRESS SYNDROME 22 0.0104
202 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 22 0.0103
203 BODY TEMPERATURE ABNORMAL 19 0.0103
204 RESPIRATORY TRACT INFECTION VIRAL 24 0.0103
205 YELLOW SKIN 48 0.0102
206 UNEVALUABLE EVENT 767 0.0101
207 SARS-COV-2 TEST POSITIVE 129 0.0098
208 RHINOVIRUS INFECTION 38 0.0098
209 URINE OUTPUT DECREASED 85 0.0097
210 BODY TEMPERATURE INCREASED 198 0.0097
211 GASTROENTERITIS 141 0.0097
212 EOSINOPHIL COUNT DECREASED 23 0.0097
213 EXPOSURE DURING BREAST FEEDING 32 0.0097
214 RENAL IMPAIRMENT 807 0.0096
215 FLANK PAIN 89 0.0095
216 THROMBOSIS IN DEVICE 31 0.0094
217 PROTEIN URINE PRESENT 47 0.0094
218 HAEMATOLOGICAL INFECTION 23 0.0094
219 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 25 0.0094
220 BRAIN DEATH 29 0.0094
221 MULTIPLE ORGAN DYSFUNCTION SYNDROME 265 0.0093
222 BLOOD ALBUMIN DECREASED 74 0.0093
223 HYPERVOLAEMIA 46 0.0093
224 FOETAL GROWTH RESTRICTION 56 0.0092
225 CEREBRAL THROMBOSIS 26 0.0092
226 PULMONARY HAEMORRHAGE 71 0.0091
227 HAEMORRHAGE URINARY TRACT 23 0.0090
228 ARTHRITIS BACTERIAL 37 0.0090
229 IMMUNOSUPPRESSION 79 0.0089
230 BONE MARROW FAILURE 181 0.0089
231 HOSPITALISATION 1364 0.0089
232 BILE DUCT STONE 28 0.0088
233 STAPHYLOCOCCAL BACTERAEMIA 38 0.0087
234 INTERNATIONAL NORMALISED RATIO ABNORMAL 30 0.0087
235 NEUROLOGICAL DECOMPENSATION 20 0.0086
236 GASTROENTERITIS VIRAL 156 0.0086
237 PREGNANCY 173 0.0086
238 PNEUMONIA FUNGAL 34 0.0086
239 RENAL PAIN 91 0.0086
240 END STAGE RENAL DISEASE 156 0.0085
241 DYSPHAGIA 797 0.0084
242 CATHETER SITE HAEMORRHAGE 21 0.0084
243 MATERNAL EXPOSURE DURING BREAST FEEDING 34 0.0084
244 OLIGURIA 52 0.0084
245 SYSTEMIC CANDIDA 21 0.0084
246 SCLERODERMA 30 0.0082
247 PROTEIN TOTAL DECREASED 31 0.0082
248 MUSCLE STRAIN 71 0.0082
249 PORTAL HYPERTENSION 25 0.0081
250 PYELONEPHRITIS 70 0.0081
251 HAEMATURIA 276 0.0081
252 LOW BIRTH WEIGHT BABY 64 0.0080
253 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 22 0.0080
254 SPLENOMEGALY 93 0.0079
255 ANIMAL BITE 21 0.0079
256 BLOOD POTASSIUM ABNORMAL 21 0.0079
257 BLOOD CALCIUM DECREASED 88 0.0078
258 ESCHERICHIA INFECTION 64 0.0078
259 BLOOD CHLORIDE DECREASED 20 0.0077
260 KLEBSIELLA INFECTION 39 0.0077
261 ORGANISING PNEUMONIA 38 0.0077
262 FATIGUE 5908 0.0076
263 AUTOIMMUNE HAEMOLYTIC ANAEMIA 26 0.0076
264 ARTHRITIS INFECTIVE 35 0.0075
265 CHOLELITHIASIS 247 0.0075
266 CYTOMEGALOVIRUS INFECTION REACTIVATION 33 0.0075
267 UPPER RESPIRATORY TRACT INFECTION 345 0.0075
268 HAEMOGLOBIN INCREASED 34 0.0074
269 BLOOD CULTURE POSITIVE 22 0.0073
270 NASOPHARYNGITIS 1335 0.0072
271 CHOLECYSTITIS 86 0.0072
272 RENAL FUNCTION TEST ABNORMAL 33 0.0071
273 TONSILLITIS 37 0.0071
274 PYREXIA 2435 0.0070
275 EXPOSURE VIA BREAST MILK 28 0.0070
276 BRAIN HERNIATION 21 0.0070
277 GASTROINTESTINAL INFECTION 63 0.0070
278 NEPHROTIC SYNDROME 48 0.0070
279 BLOOD DISORDER 56 0.0070
280 PREMATURE DELIVERY 111 0.0070
281 CARDIOPULMONARY FAILURE 27 0.0069
282 PNEUMOCYSTIS JIROVECII PNEUMONIA 69 0.0069
283 ASPERGILLUS INFECTION 45 0.0068
284 MUSCLE FATIGUE 29 0.0068
285 ENTEROCOCCAL INFECTION 33 0.0068
286 STAPHYLOCOCCAL INFECTION 222 0.0067
287 BRONCHOPULMONARY ASPERGILLOSIS 52 0.0067
288 BACTERIAL INFECTION 124 0.0066
289 ABDOMINAL PAIN 1544 0.0066
290 SEPSIS 739 0.0066
291 POST PROCEDURAL HAEMORRHAGE 77 0.0066
292 PNEUMONIA VIRAL 21 0.0066
293 AZOTAEMIA 26 0.0065
294 PLATELET COUNT INCREASED 84 0.0064
295 LYMPHOCYTE COUNT INCREASED 21 0.0064
296 ACUTE PULMONARY OEDEMA 36 0.0064
297 HYPERTENSIVE CRISIS 71 0.0064
298 INFECTION 914 0.0063
299 INFLUENZA 703 0.0063
300 SINUS HEADACHE 37 0.0062
301 BLOOD POTASSIUM INCREASED 101 0.0062
302 FACIAL PARESIS 22 0.0062
303 LOWER RESPIRATORY TRACT INFECTION 282 0.0062
304 INTERNATIONAL NORMALISED RATIO DECREASED 25 0.0062
305 HERPES SIMPLEX 40 0.0061
306 VENOUS THROMBOSIS 24 0.0061
307 BACK PAIN 1417 0.0061
308 INTESTINAL PERFORATION 68 0.0061
309 THROMBOSIS 487 0.0060
310 ANAEMIA 1154 0.0060
311 FULL BLOOD COUNT DECREASED 121 0.0060
312 PNEUMONIA BACTERIAL 55 0.0060
313 FOETAL DEATH 31 0.0060
314 NEUROLOGICAL SYMPTOM 34 0.0059
315 STREPTOCOCCAL INFECTION 33 0.0059
316 VITAMIN B12 DEFICIENCY 24 0.0059
317 DISEASE COMPLICATION 27 0.0059
318 CYTOPENIA 72 0.0059
319 RENAL FAILURE CHRONIC 45 0.0058
320 WHITE BLOOD CELL COUNT DECREASED 632 0.0058
321 PHARYNGITIS 72 0.0058
322 PALLOR 157 0.0058
323 SEPTIC SHOCK 251 0.0058
324 BLOOD PRESSURE ABNORMAL 114 0.0057
325 MENORRHAGIA 112 0.0057
326 MUSCULAR WEAKNESS 648 0.0057
327 BLOOD CREATINE INCREASED 25 0.0056
328 BLOOD TEST ABNORMAL 79 0.0056
329 LEUKAEMIA 53 0.0056
330 HEADACHE 3490 0.0056
331 CLOSTRIDIUM DIFFICILE INFECTION 121 0.0055
332 RESPIRATORY SYNCYTIAL VIRUS INFECTION 48 0.0055
333 OFF LABEL USE 4826 0.0055
334 VASCULAR DEVICE INFECTION 25 0.0055
335 RENAL TUBULAR NECROSIS 54 0.0055
336 RHINORRHOEA 355 0.0055
337 BLOOD MAGNESIUM DECREASED 47 0.0054
338 ASTHENIA 2045 0.0054
339 URINARY TRACT INFECTION 923 0.0054
340 PHOTOPHOBIA 101 0.0054
341 CONTUSION 516 0.0054
342 OROPHARYNGEAL PAIN 496 0.0054
343 IRON DEFICIENCY 24 0.0053
344 PREMATURE BABY 160 0.0053
345 NECK PAIN 297 0.0053
346 CHOLECYSTITIS ACUTE 30 0.0053
347 SKIN ABRASION 25 0.0053
348 BLOOD POTASSIUM DECREASED 159 0.0053
349 CLOSTRIDIUM DIFFICILE COLITIS 56 0.0053
350 ARTHROPOD BITE 39 0.0053
351 NECROSIS 29 0.0052
352 UTERINE LEIOMYOMA 38 0.0052
353 OESOPHAGEAL DISORDER 20 0.0052
354 PERICARDIAL EFFUSION 120 0.0052
355 PETECHIAE 54 0.0052
356 HOSPICE CARE 51 0.0052
357 NEUTROPHIL COUNT DECREASED 210 0.0051
358 MENINGITIS ASEPTIC 23 0.0051
359 EXTRAVASATION 21 0.0051
360 HAND FRACTURE 36 0.0051
361 CELLULITIS 256 0.0051
362 ASCITES 149 0.0051
363 URINE ABNORMALITY 23 0.0051
364 THROMBOCYTOPENIA 563 0.0050
365 ACUTE GRAFT VERSUS HOST DISEASE 23 0.0050
366 HYPERTENSION 1064 0.0050
367 SLUGGISHNESS 51 0.0050
368 INCORRECT DOSE ADMINISTERED 1128 0.0049
369 IMMUNODEFICIENCY 73 0.0049
370 PANCREATIC DISORDER 24 0.0049
371 PRODUCT TEMPERATURE EXCURSION ISSUE 25 0.0049
372 GENERAL PHYSICAL CONDITION ABNORMAL 33 0.0049
373 LOCALISED INFECTION 117 0.0048
374 BLOOD PRESSURE INCREASED 739 0.0048
375 LUNG INFECTION 75 0.0048
376 PULMONARY ALVEOLAR HAEMORRHAGE 27 0.0048
377 FAECES SOFT 35 0.0048
378 RESPIRATORY TRACT INFECTION 125 0.0048
379 POSTOPERATIVE WOUND INFECTION 32 0.0047
380 PANCYTOPENIA 264 0.0047
381 INTESTINAL ISCHAEMIA 26 0.0047
382 HAEMORRHOIDAL HAEMORRHAGE 23 0.0047
383 INSURANCE ISSUE 72 0.0047
384 CONDITION AGGRAVATED 1423 0.0047
385 INTRACRANIAL PRESSURE INCREASED 26 0.0047
386 PERITONITIS 96 0.0046
387 OEDEMA 251 0.0046
388 WOUND INFECTION 50 0.0046
389 CARDIAC VALVE DISEASE 26 0.0045
390 RESPIRATORY DISTRESS 124 0.0045
391 RENAL DISORDER 207 0.0044
392 GENERAL SYMPTOM 33 0.0044
393 NEUTROPHIL COUNT INCREASED 45 0.0044
394 DYSARTHRIA 165 0.0044
395 SUBCUTANEOUS ABSCESS 21 0.0044
396 HEPATOMEGALY 43 0.0044
397 MUSCULOSKELETAL DISCOMFORT 75 0.0044
398 PHARYNGITIS STREPTOCOCCAL 47 0.0043
399 NASAL CONGESTION 255 0.0043
400 PULMONARY OEDEMA 194 0.0043
401 HAEMODYNAMIC INSTABILITY 33 0.0043
402 SPUTUM DISCOLOURED 41 0.0043
403 EAR PAIN 84 0.0043
404 MULTI-ORGAN FAILURE 74 0.0043
405 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 32 0.0043
406 HYPOGAMMAGLOBULINAEMIA 28 0.0043
407 ACUTE MYELOID LEUKAEMIA 66 0.0042
408 UROSEPSIS 39 0.0042
409 CANDIDA INFECTION 71 0.0042
410 BRAIN OEDEMA 53 0.0042
411 DISSEMINATED INTRAVASCULAR COAGULATION 59 0.0042
412 LYMPHOCYTE COUNT DECREASED 74 0.0042
413 RENAL FAILURE 555 0.0042
414 DECREASED IMMUNE RESPONSIVENESS 41 0.0042
415 BREAST MASS 28 0.0042
416 INFUSION SITE SWELLING 26 0.0041
417 MALAISE 1798 0.0041
418 EAR INFECTION 109 0.0041
419 URINE ODOUR ABNORMAL 24 0.0041
420 CEREBRAL ISCHAEMIA 21 0.0041
421 MIGRAINE 389 0.0041
422 CHOLANGITIS 25 0.0040
423 ERYSIPELAS 20 0.0040
424 PRODUCTIVE COUGH 190 0.0040
425 PRODUCT PREPARATION ISSUE 26 0.0040
426 MUSCULOSKELETAL PAIN 207 0.0039
427 TOOTH INFECTION 52 0.0039
428 KIDNEY INFECTION 77 0.0039
429 DYSPNOEA 2196 0.0039
430 HERPES ZOSTER 222 0.0039
431 LEUKOPENIA 193 0.0039
432 LIMB INJURY 104 0.0038
433 DECUBITUS ULCER 31 0.0038
434 NEPHROLITHIASIS 173 0.0038
435 COUGH 1057 0.0038
436 TERMINAL STATE 25 0.0037
437 INFUSION RELATED REACTION 247 0.0037
438 PERIPHERAL SWELLING 574 0.0037
439 GENERALISED OEDEMA 46 0.0037
440 CHILLS 434 0.0037
441 FLUID RETENTION 188 0.0037
442 ACTIVITIES OF DAILY LIVING IMPAIRED 73 0.0037
443 PNEUMONIA 1193 0.0037
444 EPISTAXIS 275 0.0037
445 MALNUTRITION 41 0.0037
446 CARDIOMYOPATHY 54 0.0037
447 MUSCULOSKELETAL STIFFNESS 320 0.0036
448 LIMB DISCOMFORT 113 0.0036
449 APPENDICITIS 34 0.0036
450 TOOTH ABSCESS 37 0.0036
451 WHITE BLOOD CELL COUNT INCREASED 139 0.0036
452 LUNG INFILTRATION 32 0.0036
453 WOUND 101 0.0036
454 EMBOLISM 30 0.0036
455 RESPIRATORY FAILURE 263 0.0036
456 GALLBLADDER DISORDER 64 0.0036
457 BLOOD PRESSURE DECREASED 238 0.0036
458 IMMUNE SYSTEM DISORDER 47 0.0036
459 PULMONARY CONGESTION 47 0.0036
460 SEIZURE 410 0.0035
461 SINUSITIS 363 0.0035
462 PAIN IN EXTREMITY 1042 0.0035
463 OSTEOMYELITIS 64 0.0035
464 FURUNCLE 28 0.0035
465 EPSTEIN-BARR VIRUS INFECTION 22 0.0035
466 VASCULITIS 41 0.0035
467 LACERATION 33 0.0035
468 HEAD DISCOMFORT 62 0.0035
469 HYDRONEPHROSIS 26 0.0035
470 ENCEPHALITIS 24 0.0035
471 HAEMORRHAGIC STROKE 27 0.0035
472 MENTAL STATUS CHANGES 96 0.0035
473 PLEURAL EFFUSION 210 0.0034
474 CHEST PAIN 638 0.0034
475 OEDEMA PERIPHERAL 419 0.0034
476 FOOT FRACTURE 65 0.0034
477 SINUS CONGESTION 46 0.0034
478 VITAMIN D DECREASED 29 0.0034
479 THERAPEUTIC RESPONSE SHORTENED 112 0.0034
480 TOOTHACHE 61 0.0034
481 GINGIVAL BLEEDING 46 0.0034
482 HERNIA 65 0.0034
483 GOUT 60 0.0033
484 INFLUENZA LIKE ILLNESS 275 0.0033
485 SUBARACHNOID HAEMORRHAGE 34 0.0033
486 LETHARGY 191 0.0033
487 COVID-19 PNEUMONIA 39 0.0033
488 OVARIAN CYST 33 0.0033
489 COAGULOPATHY 55 0.0033
490 ELECTROLYTE IMBALANCE 38 0.0033
491 ABORTION SPONTANEOUS 130 0.0032
492 CHOKING 63 0.0032
493 CHOLESTASIS 62 0.0032
494 DEATH 2768 0.0032
495 HYPERSOMNIA 92 0.0032
496 TEMPERATURE INTOLERANCE 33 0.0032
497 HEPATIC CIRRHOSIS 60 0.0032
498 VOMITING 1498 0.0032
499 WALKING AID USER 21 0.0032
500 INFUSION SITE PAIN 41 0.0032
501 SEASONAL ALLERGY 45 0.0032
502 NEURALGIA 77 0.0032
503 SYSTEMIC LUPUS ERYTHEMATOSUS 112 0.0032
504 CARDIO-RESPIRATORY ARREST 131 0.0031
505 MYALGIA 532 0.0031
506 ERECTILE DYSFUNCTION 80 0.0031
507 CYSTITIS 99 0.0031
508 DIARRHOEA HAEMORRHAGIC 29 0.0031
509 MUSCULOSKELETAL CHEST PAIN 48 0.0031
510 CAESAREAN SECTION 36 0.0031
511 FUNGAL INFECTION 103 0.0031
512 HYPERBILIRUBINAEMIA 32 0.0031
513 HEPATIC FAILURE 93 0.0031
514 GENERALISED TONIC-CLONIC SEIZURE 51 0.0031
515 AUTOIMMUNE DISORDER 30 0.0031
516 BONE PAIN 180 0.0031
517 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 22 0.0031
518 DIVERTICULITIS 85 0.0031
519 FEELING COLD 84 0.0030
520 DYSSTASIA 88 0.0030
521 APHASIA 91 0.0030
522 HAEMATOMA 78 0.0030
523 EATING DISORDER 64 0.0030
524 MASS 42 0.0030
525 MITRAL VALVE INCOMPETENCE 34 0.0030
526 EOSINOPHIL COUNT INCREASED 25 0.0030
527 SKIN MASS 20 0.0030
528 DENTAL CARIES 33 0.0030
529 CYST 37 0.0030
530 CEREBRAL HAEMORRHAGE 106 0.0030
531 SPEECH DISORDER 155 0.0030
532 DEHYDRATION 393 0.0029
533 BODY TEMPERATURE DECREASED 29 0.0029
534 BRONCHITIS 218 0.0029
535 LIGAMENT SPRAIN 29 0.0029
536 INCONTINENCE 31 0.0029
537 POLYURIA 24 0.0029
538 EYE INFECTION 33 0.0029
539 VISUAL FIELD DEFECT 21 0.0029
540 CHOLECYSTECTOMY 33 0.0029
541 CARDIAC ARREST 238 0.0029
542 PULMONARY HYPERTENSION 60 0.0029
543 MOUTH HAEMORRHAGE 21 0.0029
544 DEVICE OCCLUSION 40 0.0028
545 CONCUSSION 22 0.0028
546 HEMIPARESIS 48 0.0028
547 SCIATICA 45 0.0028
548 NERVE COMPRESSION 26 0.0028
549 FACIAL PARALYSIS 24 0.0028
550 CARDIAC FAILURE 226 0.0028
551 DEPRESSED MOOD 148 0.0028
552 ROAD TRAFFIC ACCIDENT 117 0.0028
553 HEAD INJURY 88 0.0028
554 ACUTE RESPIRATORY DISTRESS SYNDROME 49 0.0028
555 ORAL HERPES 54 0.0028
556 HAEMOPTYSIS 77 0.0028
557 ABSCESS 44 0.0028
558 ACUTE RESPIRATORY FAILURE 53 0.0028
559 DEEP VEIN THROMBOSIS 178 0.0027
560 DISEASE RECURRENCE 130 0.0027
561 SUBDURAL HAEMATOMA 39 0.0027
562 NERVOUS SYSTEM DISORDER 85 0.0027
563 GENERAL PHYSICAL HEALTH DETERIORATION 315 0.0027
564 TOOTH FRACTURE 30 0.0027
565 BLOOD SODIUM DECREASED 51 0.0027
566 HYPOALBUMINAEMIA 21 0.0027
567 EYE HAEMORRHAGE 36 0.0027
568 PELVIC FRACTURE 21 0.0027
569 TENDERNESS 28 0.0027
570 CHEST DISCOMFORT 275 0.0027
571 PULMONARY MASS 40 0.0027
572 THERAPY NON-RESPONDER 120 0.0027
573 PANCREATITIS 141 0.0027
574 BLOOD PRESSURE SYSTOLIC INCREASED 52 0.0027
575 MYOPATHY 23 0.0027
576 CARDIAC MURMUR 23 0.0027
577 FOETAL EXPOSURE DURING PREGNANCY 216 0.0027
578 MUSCLE TIGHTNESS 43 0.0027
579 ASPIRATION 29 0.0026
580 FULL BLOOD COUNT ABNORMAL 28 0.0026
581 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 77 0.0026
582 NEUTROPENIA 357 0.0026
583 BLOOD ALKALINE PHOSPHATASE INCREASED 65 0.0026
584 LIVER DISORDER 116 0.0026
585 FEEDING DISORDER 53 0.0026
586 PURPURA 23 0.0026
587 BRAIN INJURY 26 0.0026
588 ARTHRALGIA 1076 0.0026
589 POST PROCEDURAL INFECTION 21 0.0026
590 ABDOMINAL DISTENSION 267 0.0026
591 DYSPHONIA 149 0.0025
592 NAUSEA 1999 0.0025
593 HEART RATE IRREGULAR 57 0.0025
594 RENAL CYST 20 0.0025
595 RESPIRATORY DISORDER 75 0.0025
596 SWELLING FACE 163 0.0025
597 IRON DEFICIENCY ANAEMIA 23 0.0025
598 ENCEPHALOPATHY 61 0.0025
599 JOINT INJURY 53 0.0025
600 HYPOTENSION 494 0.0025
601 SHOCK HAEMORRHAGIC 20 0.0025
602 ANAL INCONTINENCE 22 0.0024
603 VITREOUS FLOATERS 24 0.0024
604 DRUG EFFECT LESS THAN EXPECTED 36 0.0024
605 FALL 806 0.0024
606 PAIN 1484 0.0024
607 ABDOMINAL PAIN LOWER 61 0.0024
608 SLEEP APNOEA SYNDROME 46 0.0024
609 LIVER FUNCTION TEST ABNORMAL 70 0.0024
610 SKIN INFECTION 27 0.0024
611 BLOOD CALCIUM INCREASED 21 0.0024
612 HAEMORRHAGE 250 0.0024
613 GROIN PAIN 21 0.0024
614 ARTHRITIS 188 0.0024
615 OSTEONECROSIS 78 0.0024
616 BLOOD GLUCOSE FLUCTUATION 26 0.0024
617 DIZZINESS POSTURAL 23 0.0024
618 FEELING ABNORMAL 568 0.0024
619 HAEMATEMESIS 60 0.0024
620 UPPER LIMB FRACTURE 47 0.0024
621 BEDRIDDEN 31 0.0024
622 CARDIOMEGALY 29 0.0024
623 COLON CANCER 35 0.0023
624 NERVE INJURY 26 0.0023
625 HEART RATE DECREASED 82 0.0023
626 TOOTH EXTRACTION 29 0.0023
627 CENTRAL NERVOUS SYSTEM LESION 32 0.0023
628 GASTROINTESTINAL HAEMORRHAGE 194 0.0023
629 ILL-DEFINED DISORDER 141 0.0023
630 OSTEOPOROSIS 95 0.0023
631 BASAL CELL CARCINOMA 36 0.0023
632 LUNG DISORDER 113 0.0023
633 GAIT DISTURBANCE 440 0.0023
634 BLOOD PRESSURE FLUCTUATION 55 0.0023
635 INCREASED TENDENCY TO BRUISE 21 0.0023
636 LIVER FUNCTION TEST INCREASED 49 0.0023
637 ILLNESS 235 0.0023
638 THYROID DISORDER 35 0.0023
639 INTERVERTEBRAL DISC DEGENERATION 21 0.0023
640 VAGINAL HAEMORRHAGE 98 0.0023
641 FACE OEDEMA 38 0.0023
642 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 404 0.0022
643 INTERVERTEBRAL DISC PROTRUSION 49 0.0022
644 PNEUMONIA ASPIRATION 56 0.0022
645 FACIAL PAIN 20 0.0022
646 HEPATITIS C 27 0.0022
647 SECRETION DISCHARGE 28 0.0022
648 NIGHT SWEATS 72 0.0022
649 PULMONARY EMBOLISM 212 0.0022
650 HEPATITIS 57 0.0022
651 ABDOMINAL PAIN UPPER 458 0.0022
652 SINUS DISORDER 44 0.0022
653 CONFUSIONAL STATE 359 0.0022
654 SCAR 38 0.0022
655 SPINAL PAIN 26 0.0022
656 GAIT INABILITY 74 0.0022
657 HYPOAESTHESIA 331 0.0022
658 DYSURIA 81 0.0022
659 LYMPHOMA 34 0.0022
660 RETINAL DETACHMENT 20 0.0022
661 DIZZINESS 1085 0.0022
662 ATELECTASIS 21 0.0022
663 MOBILITY DECREASED 156 0.0022
664 MUSCLE SPASMS 398 0.0022
665 MALIGNANT MELANOMA 29 0.0022
666 CHRONIC KIDNEY DISEASE 164 0.0022
667 SKIN LESION 59 0.0021
668 BLOOD TRIGLYCERIDES INCREASED 38 0.0021
669 APHONIA 30 0.0021
670 RESTLESS LEGS SYNDROME 39 0.0021
671 PNEUMOTHORAX 34 0.0021
672 INTERNATIONAL NORMALISED RATIO INCREASED 61 0.0021
673 ACUTE KIDNEY INJURY 327 0.0021
674 POOR QUALITY SLEEP 46 0.0021
675 SQUAMOUS CELL CARCINOMA 20 0.0021
676 C-REACTIVE PROTEIN INCREASED 77 0.0021
677 HYPOPHAGIA 54 0.0021
678 ASPARTATE AMINOTRANSFERASE INCREASED 112 0.0021
679 INJECTION SITE EXTRAVASATION 26 0.0021
680 HAEMORRHOIDS 41 0.0021
681 DIARRHOEA 1356 0.0021
682 JOINT STIFFNESS 55 0.0021
683 ACCIDENT 25 0.0021
684 ILEUS 26 0.0021
685 VISUAL IMPAIRMENT 259 0.0021
686 SUPRAVENTRICULAR TACHYCARDIA 20 0.0021
687 SWELLING 195 0.0021
688 HAEMORRHAGE INTRACRANIAL 31 0.0021
689 BLINDNESS 84 0.0021
690 COVID-19 361 0.0021
691 UNRESPONSIVE TO STIMULI 53 0.0021
692 VITAMIN D DEFICIENCY 20 0.0020
693 FISTULA 23 0.0020
694 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 112 0.0020
695 MOUTH ULCERATION 43 0.0020
696 THERAPY CHANGE 20 0.0020
697 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 106 0.0020
698 RECTAL HAEMORRHAGE 87 0.0020
699 SKIN DISCOLOURATION 93 0.0020
700 BACK INJURY 22 0.0020
701 ARTERIOSCLEROSIS 19 0.0020
702 PULMONARY THROMBOSIS 22 0.0020
703 HYPOXIA 71 0.0020
704 PHARYNGEAL OEDEMA 31 0.0020
705 MACULAR DEGENERATION 24 0.0020
706 ANKLE FRACTURE 31 0.0020
707 WRIST FRACTURE 24 0.0020
708 EOSINOPHILIA 35 0.0020
709 EJECTION FRACTION DECREASED 31 0.0020
710 ATRIAL FIBRILLATION 194 0.0020
711 HIP FRACTURE 64 0.0020
712 LEUKOCYTOSIS 36 0.0020
713 VISION BLURRED 272 0.0020
714 BRAIN FOG 31 0.0020
715 ACUTE HEPATIC FAILURE 27 0.0020
716 TREATMENT NONCOMPLIANCE 108 0.0020
717 MUSCLE ATROPHY 25 0.0020
718 VERTIGO 120 0.0020
719 PANCREATITIS ACUTE 44 0.0020
720 PARALYSIS 28 0.0020
721 SPINAL FRACTURE 39 0.0019
722 RIB FRACTURE 40 0.0019
723 PHOTOSENSITIVITY REACTION 32 0.0019
724 PRESYNCOPE 47 0.0019
725 DEMENTIA 54 0.0019
726 COLD SWEAT 34 0.0019
727 COMPLICATION ASSOCIATED WITH DEVICE 28 0.0019
728 CEREBRAL INFARCTION 47 0.0019
729 THERAPY PARTIAL RESPONDER 30 0.0019
730 OESOPHAGITIS 21 0.0019
731 OXYGEN SATURATION DECREASED 108 0.0019
732 PALPITATIONS 225 0.0019
733 IMPAIRED HEALING 63 0.0019
734 DECREASED APPETITE 445 0.0019
735 CATARACT 114 0.0019
736 WEIGHT DECREASED 533 0.0019
737 RENAL FAILURE ACUTE 81 0.0019
738 ALOPECIA 373 0.0019
739 COLITIS 72 0.0019
740 THROAT IRRITATION 85 0.0019
741 LYMPHADENOPATHY 67 0.0019
742 NEOPLASM MALIGNANT 126 0.0019
743 THROAT TIGHTNESS 51 0.0019
744 HEPATIC ENZYME INCREASED 128 0.0019
745 HEART RATE INCREASED 186 0.0019
746 DEAFNESS 49 0.0019
747 SMALL INTESTINAL OBSTRUCTION 23 0.0019
748 SKIN CANCER 40 0.0019
749 EYE DISORDER 61 0.0019
750 TACHYCARDIA 164 0.0018
751 FAECES DISCOLOURED 40 0.0018
752 HIP ARTHROPLASTY 28 0.0018
753 SNEEZING 41 0.0018
754 PERIPHERAL COLDNESS 25 0.0018
755 ABDOMINAL DISCOMFORT 304 0.0018
756 FEELING HOT 111 0.0018
757 BALANCE DISORDER 156 0.0018
758 PRODUCT PREPARATION ERROR 37 0.0018
759 POLLAKIURIA 75 0.0018
760 GASTROINTESTINAL DISORDER 160 0.0018
761 OCULAR DISCOMFORT 20 0.0018
762 AGRANULOCYTOSIS 33 0.0018
763 LOSS OF CONSCIOUSNESS 227 0.0018
764 DISORIENTATION 70 0.0018
765 SOMNOLENCE 355 0.0018
766 CEREBROVASCULAR ACCIDENT 298 0.0018
767 CARDIAC FAILURE CONGESTIVE 141 0.0018
768 TRANSAMINASES INCREASED 39 0.0018
769 COMA 83 0.0017
770 ALANINE AMINOTRANSFERASE INCREASED 107 0.0017
771 CARDIOGENIC SHOCK 25 0.0017
772 BLOOD GLUCOSE ABNORMAL 32 0.0017
773 JOINT SWELLING 209 0.0017
774 SYNCOPE 173 0.0017
775 TRANSIENT ISCHAEMIC ATTACK 58 0.0017
776 GASTRITIS 45 0.0017
777 SHOCK 39 0.0017
778 HEPATOCELLULAR INJURY 24 0.0017
779 DISCOMFORT 103 0.0017
780 URINARY INCONTINENCE 50 0.0017
781 WEIGHT INCREASED 374 0.0017
782 CARDIAC DISORDER 156 0.0017
783 THERAPEUTIC RESPONSE DECREASED 101 0.0017
784 INCORRECT PRODUCT ADMINISTRATION DURATION 36 0.0017
785 PROCEDURAL PAIN 46 0.0017
786 HYPOKINESIA 24 0.0017
787 EYE PAIN 93 0.0016
788 URINARY RETENTION 55 0.0016
789 ROTATOR CUFF SYNDROME 21 0.0016
790 COGNITIVE DISORDER 76 0.0016
791 LYMPHOPENIA 23 0.0016
792 MEMORY IMPAIRMENT 223 0.0016
793 ALTERED STATE OF CONSCIOUSNESS 35 0.0016
794 HEPATIC STEATOSIS 30 0.0016
795 INSOMNIA 426 0.0016
796 RASH GENERALISED 41 0.0016
797 HYPERSENSITIVITY 293 0.0016
798 RESPIRATORY TRACT CONGESTION 25 0.0016
799 ISCHAEMIC STROKE 28 0.0016
800 TREMOR 260 0.0016
801 POST PROCEDURAL COMPLICATION 30 0.0016
802 HYPOKALAEMIA 72 0.0016
803 BLINDNESS UNILATERAL 22 0.0016
804 EYE SWELLING 58 0.0016
805 DELIRIUM 54 0.0016
806 PARAESTHESIA 244 0.0015
807 PERICARDITIS 26 0.0015
808 THERAPEUTIC PRODUCT EFFECT DECREASED 69 0.0015
809 IMPAIRED GASTRIC EMPTYING 21 0.0015
810 ABASIA 38 0.0015
811 DIABETES MELLITUS 117 0.0015
812 CYANOSIS 24 0.0015
813 ACUTE MYOCARDIAL INFARCTION 45 0.0015
814 HAEMATOCHEZIA 84 0.0015
815 SKIN ULCER 39 0.0015
816 ANXIETY 427 0.0015
817 CARPAL TUNNEL SYNDROME 21 0.0015
818 DRUG INEFFECTIVE 1967 0.0015
819 AMNESIA 97 0.0015
820 LACRIMATION INCREASED 45 0.0015
821 TOOTH DISORDER 33 0.0015
822 RASH MACULO-PAPULAR 33 0.0015
823 PANIC ATTACK 54 0.0015
824 HYPERHIDROSIS 190 0.0015
825 MATERNAL EXPOSURE DURING PREGNANCY 131 0.0015
826 HYPERKALAEMIA 51 0.0015
827 DRUG LEVEL INCREASED 24 0.0014
828 OBESITY 23 0.0014
829 BURNING SENSATION 101 0.0014
830 LOCAL SWELLING 25 0.0014
831 ANAPHYLACTIC REACTION 79 0.0014
832 METASTASES TO LIVER 25 0.0014
833 TENDONITIS 22 0.0014
834 MELAENA 31 0.0014
835 RETCHING 30 0.0014
836 CONJUNCTIVITIS 26 0.0014
837 THIRST 25 0.0014
838 DEPRESSION 316 0.0014
839 ADVERSE EVENT 127 0.0014
840 RASH PRURITIC 74 0.0014
841 INTESTINAL OBSTRUCTION 51 0.0014
842 TINNITUS 62 0.0013
843 MUSCLE TWITCHING 31 0.0013
844 ORAL PAIN 30 0.0013
845 RASH 581 0.0013
846 PRODUCT DOSE OMISSION 87 0.0013
847 HYPOAESTHESIA ORAL 20 0.0013
848 ULCER 21 0.0013
849 SLEEP DISORDER 93 0.0013
850 DISTURBANCE IN ATTENTION 71 0.0013
851 HYPOTHYROIDISM 42 0.0013
852 MENTAL DISORDER 57 0.0013
853 MOVEMENT DISORDER 42 0.0013
854 MUCOSAL INFLAMMATION 34 0.0013
855 CRYING 47 0.0013
856 GASTROOESOPHAGEAL REFLUX DISEASE 104 0.0013
857 PANCREATIC CARCINOMA 37 0.0013
858 CONSTIPATION 279 0.0013
859 GASTRIC ULCER 24 0.0013
860 INCREASED APPETITE 24 0.0013
861 AMENORRHOEA 22 0.0013
862 PRURITUS GENERALISED 27 0.0012
863 INFLAMMATION 64 0.0012
864 BACK DISORDER 20 0.0012
865 ARRHYTHMIA 58 0.0012
866 BLISTER 68 0.0012
867 INCORRECT DRUG ADMINISTRATION DURATION 34 0.0012
868 TOOTH LOSS 25 0.0012
869 NEUROPATHY PERIPHERAL 112 0.0012
870 CONVULSION 67 0.0012
871 HEPATOTOXICITY 26 0.0012
872 IRRITABLE BOWEL SYNDROME 25 0.0012
873 AGEUSIA 29 0.0012
874 FRACTURE 22 0.0012
875 DISEASE PROGRESSION 137 0.0012
876 SKIN DISORDER 38 0.0011
877 PNEUMONITIS 31 0.0011
878 NO ADVERSE EVENT 206 0.0011
879 FEBRILE NEUTROPENIA 75 0.0011
880 BLOOD GLUCOSE INCREASED 213 0.0011
881 PAIN IN JAW 32 0.0011
882 NERVOUSNESS 59 0.0011
883 DEVICE ISSUE 101 0.0011
884 BLOOD GLUCOSE DECREASED 53 0.0011
885 PLASMA CELL MYELOMA 43 0.0011
886 DRUG EFFECT INCOMPLETE 40 0.0011
887 BONE DISORDER 20 0.0011
888 DRUG RESISTANCE 28 0.0011
889 URTICARIA 181 0.0011
890 RHABDOMYOLYSIS 45 0.0011
891 SURGERY 63 0.0011
892 MENTAL IMPAIRMENT 26 0.0011
893 HEPATIC FUNCTION ABNORMAL 40 0.0011
894 HYPOACUSIS 46 0.0011
895 CARDIOVASCULAR DISORDER 27 0.0011
896 DISABILITY 21 0.0011
897 HOT FLUSH 80 0.0011
898 PRURITUS 401 0.0010
899 HYPERGLYCAEMIA 38 0.0010
900 GLAUCOMA 20 0.0010
901 GAMMA-GLUTAMYLTRANSFERASE INCREASED 23 0.0010
902 FIBROMYALGIA 25 0.0010
903 DYSPEPSIA 101 0.0010
904 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 72 0.0010
905 STOMATITIS 61 0.0010
906 ERYTHEMA 206 0.0010
907 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 48 0.0010
908 RESPIRATORY ARREST 27 0.0010
909 OCULAR HYPERAEMIA 46 0.0010
910 EPILEPSY 29 0.0009
911 WHEEZING 56 0.0009
912 BLOOD CHOLESTEROL INCREASED 44 0.0009
913 ANGINA PECTORIS 27 0.0009
914 ADVERSE DRUG REACTION 84 0.0009
915 MYOCARDIAL INFARCTION 163 0.0009
916 RASH ERYTHEMATOUS 44 0.0009
917 RASH MACULAR 32 0.0009
918 DEVICE DISLOCATION 39 0.0009
919 OSTEOARTHRITIS 38 0.0009
920 MOOD ALTERED 24 0.0009
921 LUNG NEOPLASM MALIGNANT 36 0.0009
922 METABOLIC ACIDOSIS 28 0.0009
923 RENAL INJURY 26 0.0009
924 BRADYCARDIA 46 0.0009
925 CORONARY ARTERY DISEASE 26 0.0009
926 PAIN OF SKIN 23 0.0009
927 FEMUR FRACTURE 26 0.0008
928 MENSTRUATION IRREGULAR 22 0.0008
929 DYSKINESIA 33 0.0008
930 INTERSTITIAL LUNG DISEASE 39 0.0008
931 COLITIS ULCERATIVE 36 0.0008
932 GASTRIC DISORDER 27 0.0008
933 DRUG DOSE OMISSION 130 0.0008
934 FEAR 21 0.0008
935 SWOLLEN TONGUE 24 0.0008
936 BLOOD CREATINE PHOSPHOKINASE INCREASED 22 0.0008
937 DEPRESSED LEVEL OF CONSCIOUSNESS 30 0.0008
938 LIP SWELLING 25 0.0007
939 LACTIC ACIDOSIS 24 0.0007
940 ANAPHYLACTIC SHOCK 19 0.0007
941 DRY EYE 36 0.0007
942 ARTHROPATHY 40 0.0007
943 PRODUCT DOSE OMISSION ISSUE 211 0.0007
944 IRRITABILITY 43 0.0007
945 EMOTIONAL DISORDER 22 0.0007
946 DYSGEUSIA 53 0.0007
947 TYPE 2 DIABETES MELLITUS 24 0.0007
948 ACNE 54 0.0007
949 ANGER 24 0.0007
950 ASTHMA 80 0.0007
951 FLATULENCE 40 0.0007
952 DRUG INTOLERANCE 68 0.0007
953 VISUAL ACUITY REDUCED 23 0.0007
954 MOOD SWINGS 22 0.0007
955 BREAST CANCER 64 0.0007
956 HYPOGLYCAEMIA 32 0.0007
957 FLUSHING 66 0.0006
958 AGITATION 47 0.0006
959 ANGIOEDEMA 28 0.0006
960 DRUG EFFECT DECREASED 34 0.0006
961 ABNORMAL BEHAVIOUR 25 0.0006
962 ECZEMA 32 0.0006
963 HALLUCINATION 46 0.0006
964 INTENTIONAL PRODUCT USE ISSUE 51 0.0006
965 RESTLESSNESS 21 0.0006
966 INJURY 40 0.0006
967 TREATMENT FAILURE 46 0.0006
968 DRY MOUTH 43 0.0005
969 THERAPY CESSATION 27 0.0005
970 SKIN EXFOLIATION 44 0.0005
971 EXTRA DOSE ADMINISTERED 21 0.0005
972 THERAPEUTIC RESPONSE UNEXPECTED 23 0.0005
973 RHEUMATOID ARTHRITIS 58 0.0005
974 INJECTION SITE SWELLING 38 0.0005
975 EYE IRRITATION 28 0.0005
976 HYPONATRAEMIA 26 0.0005
977 DRY SKIN 57 0.0004
978 DEVICE MALFUNCTION 30 0.0004
979 SKIN BURNING SENSATION 30 0.0004
980 PROSTATE CANCER 33 0.0004
981 PRODUCT USE IN UNAPPROVED INDICATION 100 0.0004
982 AGGRESSION 19 0.0004
983 UNDERDOSE 27 0.0004
984 MEDICATION ERROR 20 0.0004
985 SUICIDAL IDEATION 30 0.0003
986 EMOTIONAL DISTRESS 32 0.0003
987 MALIGNANT NEOPLASM PROGRESSION 25 0.0002
988 OVERDOSE 49 0.0002
989 PRODUCT USE ISSUE 40 0.0002
990 TOXICITY TO VARIOUS AGENTS 35 0.0002
991 INJECTION SITE PAIN 62 0.0002
992 INJECTION SITE ERYTHEMA 25 0.0002
993 DRUG INTERACTION 29 0.0002